I think it really worth thinking of FBR as a biotech stock. They all need heavy investment and LOTS of patience. The key difference is that biotech can fall apart in a single clinical trial, FBR is very well positioned to reach mass adoption as they have proven the milestones already in testing. All it takes is that one big green light. We’ve seen it time and again that the market moves swiftly to balance sheet changes (and wider market awareness), once they have orders and flips to a positive balance sheet investors benefit.
I think it really worth thinking of FBR as a biotech stock. They...
Add FBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.0M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.4¢ | $10.08K | 404.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2542433 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2108303 | 9 |
View Market Depth
| Last trade - 15.15pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.000 ( 4.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.5¢ | 2.4¢ | 314724 | ||
| Last updated 15.58pm 07/06/2024 ? | |||||
| FBR (ASX) Chart |